We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Starts Rolling Review of Regeneron’s Antibody Cocktail for COVID-19
EMA Starts Rolling Review of Regeneron’s Antibody Cocktail for COVID-19
The European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) has begun a rolling review of Regeneron’s REGN-COV2 antibody combination (casirivimab/imdevimab) for treating and preventing COVID-19.